Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 121915-83-1
2. Rph56vwa1a
3. Sq 33,248
4. Sq-33248
5. Calteridol Calcium (usan)
6. Calteridol Calcium [usan]
7. Tricalcium;2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
8. Unii-rph56vwa1a
9. Calteridol Calcium [usan:ban]
10. Calteridol Calcium [ii]
11. Chembl2106555
12. Calteridol Calcium [vandf]
13. Calteridol Calcium [who-dd]
14. (+-)-calcium Bis((10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))calciate(1-))
15. D03320
16. Q27288232
17. (+/-)-calcium Bis((10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))calciate(1-))
18. Calciate(1-), (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n(sup 1),n(sup 4),n(sup 7),n(sup 10),o(sup 1),o(sup 4),o(sup 7),o(sup 10))-, Calcium (2:1)
19. Calciate(1-), (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n(sup 1),n(sup 4,n(sup 7),n(sup 10),o(sup 1),o(sup 4),o(sup 7),o(sup 10))-, Calcium (2:1)
Molecular Weight | 923.1 g/mol |
---|---|
Molecular Formula | C34H58Ca3N8O14 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 10 |
Exact Mass | 922.2950211 g/mol |
Monoisotopic Mass | 922.2950211 g/mol |
Topological Polar Surface Area | 307 Ų |
Heavy Atom Count | 59 |
Formal Charge | 0 |
Complexity | 471 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?